Nucleus RadioPharma

About Nucleus RadioPharma

Nucleus RadioPharma is a full-service contract development and manufacturing organization (CDMO) dedicated to building robust and reliable clinical and commercial supply chains for targeted radiotherapies, helping radiopharmaceutical companies and innovators succeed by advancing their products from concept to market.

Products & Services

CDMO Services:Comprehensive services for radiopharmaceutical companies including research & development, supply chain management, manufacturing, and quality & regulatory support to bring targeted radiotherapies to market.

Specialties

Targeted Radiotherapies Radiopharmaceutical Development Supply Chain Management for Radioligand Therapies Manufacturing of Radiotherapeutics

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 56000000 MR: - FA: $56 million FAN: 56000000	D: 2023-10-17 FD: 2023-10-17	8 investors

Series A Latest

2023-10-17

$56.0M

8 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Stephen M. Hahn

Chief Executive Officer

K

Kathy Spencer-Pike

Chief Commercial Officer

G

Geoff Johnson

Chief Scientific Officer

J

Joe Warchol

Chief Financial Officer

R

Rebecca Totten

Senior Vice President, Human Resources

K

Kim Blackwell

Chief Development Officer

View 24 more team members with Pro

Unlock Full Team Directory

Recent News